KOSELUGO vs SPRYCEL

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 17, 2026·How we rate

Possible drug interaction. KOSELUGO and SPRYCEL are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	KOSELUGO	SPRYCEL
Rating	70/100	72/100
Pharmacy pays	—	~$839.19 /30
Type	RX	RX
Active ingredient	SELUMETINIB SULFATE	DASATINIB
Manufacturer	Astrazeneca	Bristol Myers Squibb
Dosage forms	Capsule, Powder	Tablet
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	None
Treats	Neurofibromatosis 1	Lymphoid Leukemia, Myeloid Leukemia

koselugo sprycel

Rating

70/100

72/100

Pharmacy pays

—

~$839.19 /30

Type

Active ingredient

SELUMETINIB SULFATE

DASATINIB

Manufacturer

Astrazeneca

Bristol Myers Squibb

Dosage forms

Capsule, Powder

Tablet

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Neurofibromatosis 1

Lymphoid Leukemia, Myeloid Leukemia

Frequently asked questions

Which is better-rated, Koselugo or Sprycel?

By our independent rating, Sprycel scores higher — 3.6 vs 3.5 out of 5 for Koselugo. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Koselugo and Sprycel?

Koselugo contains Selumetinib Sulfate, while Sprycel contains Dasatinib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.